ArticleApplied health economics and health policy2026
Quality-Adjusted Life Expectancy and Cost-Effectiveness Thresholds in Three High-Income Regions in Asia.
Article in Applied health economics and health policy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
BACKGROUND AND
objectiveCost-effectiveness thresholds (CETs) are essential for health technology assessments and resource allocation in healthcare. However, empirical CET estimates alongside quality-adjusted life expectancy are absent for the Hong Kong Special Administrative Region of China (Hong Kong SAR), Taiwan Province of China (Taiwan Province), and Singapore. This study aims to estimate quality-adjusted life expectancy and derive CETs in these regions.
methodsQuality-adjusted life expectancy was calculated by using the Sullivan method. The CET was estimated using the value of a statistical life-based method, adjusted for age-specific life expectancy and health utilities to derive value of a statistical quality-adjusted life-year. Population-weighted value of a statistical quality-adjusted life-year values yielded regional CETs. Final estimates were corrected for overestimation, and sensitivity analyses were conducted.
resultsQuality-adjusted life expectancy estimates at birth were 79.98, 76.73, and 79.48 quality-adjusted life-years for Hong Kong SAR, Taiwan Province, and Singapore, respectively. Base-case CETs, expressed as times of gross domestic product per capita, were 3.12 (95% confidence interval 2.38-3.88), 2.15 (95% confidence interval 0.85-3.37), and 3.30 (95% confidence interval 1.77-4.74) for the three regions, respectively. Sensitivity analyses showed CET ranges of 2.86-3.46 (Hong Kong SAR), 2.00-2.39 (Taiwan Province), and 3.07-3.66 (Singapore) times of gross domestic product per capita for utility variations, and 2.02-3.98 (Hong Kong SAR), 1.43-2.71 (Taiwan Province), and 2.11-4.23 (Singapore) times of gross domestic product per capita for discount rate changes.
conclusionsThis study provides the first value of a statistical life-based CET estimates integrated with quality-adjusted life expectancy for three high-income regions in Asia. Focusing on context-specific thresholds beyond the World Health Organization benchmarks, the current findings offer a scientific basis for health technology assessments and policy decisions.
Indexed as
Identifiers
41964789What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.